|
1
|
Smolonska J, Wijmenga C, Postma DS and
Boezen HM: Meta-analyses on suspected chronic obstructive pulmonary
disease genes: A summary of 20 years' research. Am J Respir Crit
Care Med. 180:618–631. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhong N, Wang C, Yao W, Chen P, Kang J,
Huang S, Chen B, Wang C, Ni D, Zhou Y, et al: Prevalence of chronic
obstructive pulmonary disease in China: A large, population-based
survey. Am J Respir Crit Care Med. 176:753–760. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Decramer M, Janssens W and Miravitlles M:
Chronic obstructive pulmonary disease. Lancet. 379:1341–1351. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Muro S: Cigarette smoking is the most
important causal factor for developing chronic obstructive
pulmonary disease (COPD). Nihon Rinsho. 69:1735–1740. 2011.(In
Japanese). PubMed/NCBI
|
|
5
|
Løkke A, Lange P, Scharling H, Fabricius P
and Vestbo J: Developing COPD: A 25 year follow up study of the
general population. Thorax. 61:935–939. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bush A: COPD: A pediatric disease. COPD.
5:53–67. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Viegi G, Pistelli F, Sherrill DL, Maio S,
Baldacci S and Carrozzi L: Definition, epidemiology and natural
history of COPD. Eur Respir J. 30:993–1013. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou Y, Wang C, Yao W, Chen P, Kang J,
Huang S, Chen B, Wang C, Ni D, Wang X, et al: COPD in Chinese
nonsmokers. Eur Respir J. 33:509–518. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miller M, Cho JY, Pham A, Ramsdell J and
Broide DH: Adiponectin and functional adiponectin receptor 1 are
expressed by airway epithelial cells in chronic obstructive
pulmonary disease. J Immunol. 182:684–691. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tomoda K, Yoshikawa M, Itoh T, Tamak S,
Fukuoka A, Komeda K and Kimura H: Elevated circulating plasma
adiponectin in underweight patients with COPD. Chest. 132:135–140.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chan KH, Yeung SC, Yao TJ, Ip MS, Cheung
AH, Chan-Yeung MM and Mak JC: COPD Study Group of the Hong Kong
Thoracic Society: Elevated plasma adiponectin levels in patients
with chronic obstructive pulmonary disease. Int J Tuberc Lung Dis.
14:1193–1200. 2010.PubMed/NCBI
|
|
12
|
Miller M, Pham A, Cho JY, Rosenthal P and
Broide DH: Adiponectin-deficient mice are protected against
tobacco-induced inflammation and increased emphysema. Am J Physiol
Lung Cell Mol Physiol. 299:L834–L842. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Daniele A, De Rosa A, Nigro E, Scudiero O,
Capasso M, Masullo M, de Laurentiis G, Oriani G, Sofia M and Bianco
A: Adiponectin oligomerization state and adiponectin receptors
airway expression in chronic obstructive pulmonary disease. Int J
Biochem Cell Biol. 44:563–569. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tilg H and Moschen AR: Adipocytokines:
Mediators linking adipose tissue, inflammation and immunity. Nat
Rev Immunol. 6:772–783. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wert SE: Does adiponectin play a role in
pulmonary emphysema? Am J Physiol Lung Cell Mol Physiol.
294:L1032–L1034. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Su Y, Han W, Giraldo C, De Li Y and Block
ER: Effect of cigarette smoke extract on nitric oxide synthase in
pulmonary artery endothelial cells. Am J Respir Cell Mol Biol.
19:819–825. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Damiá Ade D, Gimeno JC, Ferrer MJ,
Fabregas ML, Folch PA and Paya JM: A study of the effect of
proinflammatory cytokines on the epithelial cells of smokers, with
or without COPD. Arch Bronconeumol. 47:447–453. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Garrod R, Marshall J, Barley E, Fredericks
S and Hagan G: The relationship between inflammatory markers and
disability in chronic obstructive pulmonary disease (COPD). Prim
Care Respir J. 16:236–240. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kode A, Yang SR and Rahman I: Differential
effects of cigarette smoke on oxidative stress and proinflammatory
cytokine release in primary human airway epithelial cells and in a
variety of transformed alveolar epithelial cells. Respir Res.
7:1322006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chorostowska-Wynimko J: The role of
inflammation in the pathogenesis of chronic obstructive pulmonary
disease. Pol Merkur Lekarski. 17:203–207. 2004.(In Polish).
PubMed/NCBI
|
|
21
|
Barnes PJ, Shapiro SD and Pauwels RA:
Chronic obstructive pulmonary disease: Molecular and cellular
mechanisms. Eur Respir J. 22:672–688. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Siasos G, Tousoulis D, Kollia C, Oikonomou
E, Siasou Z, Stefanadis C and Papavassiliou AG: Adiponectin and
cardiovascular disease: Mechanisms and new therapeutic approaches.
Curr Med Chem. 19:1193–1209. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bianco A, Mazzarella G, Tu'rchiarelli V,
Nigro E, Corbi G, Scudiero O, Sofia M and Daniele A: Adiponectin:
An attractive marker for metabolic disorders in Chronic Obstructive
Pulmonary Disease (COPD). Nutrients. 5:4115–4125. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sull JW, Kim HJ, Yun JE, Park EJ, Kim G
and Jee SH: Serum adiponectin is associated with smoking status in
healthy Korean men. Endocr J. 56:73–78. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kirdar S, Serter M, Ceylan E, Sener AG,
Kavak T and Karadağ F: Adiponectin as a biomarker of systemic
inflammatory response in smoker patients with stable and
exacerbation phases of chronic obstructive pulmonary disease. Scand
J Clin Lab Invest. 69:219–224. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Summer R, Little FF, Ouchi N, Takemura Y,
Aprahamian T, Dwyer D, Fitzsimmons K, Suki B, Parameswaran H, Fine
A and Walsh K: Alveolar macrophage activation and an emphysema-like
phenotype in adiponectin-deficient mice. Am J Physiol Lung Cell Mol
Physiol. 294:L1035–L1042. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakanishi K, Takeda Y, Tetsumoto S,
Iwasaki T, Tsujino K, Kuhara H, Jin Y, Nagatomo I, Kida H, Goya S,
et al: Involvement of endothelial apoptosis underlying chronic
obstructive pulmonary disease-like phenotype in adiponectin-null
mice: Implications for therapy. Am J Respir Crit Care Med.
183:1164–1175. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yoon HI, Li Y, Man SF, Tashkin D, Wise RA,
Connett JE, Anthonisen NA, Churg A, Wright JL and Sin DD: The
complex relationship of serum adiponectin to COPD outcomes COPD and
adiponectin. Chest. 142:893–899. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chung KF: Cytokines as targets in chronic
obstructive pulmonary disease. Curr Drug Targets. 7:675–681. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Celik H, Akpinar S, Karabulut H, Oktar P,
Dursun B, Erguden HC, Gunay S and Sipit T: Evaluation of IL-8 nasal
lavage levels and the effects of nasal involvement on disease
severity in patients with stable chronic obstructive pulmonary
disease. Inflammation. 38:616–622. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Antus B and Kardos Z: Oxidative stress in
COPD: Molecular background and clinical monitoring. Curr Med Chem.
22:627–650. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
MacNee W: Pulmonary and systemic
oxidant/antioxidant imbalance in chronic obstructive pulmonary
disease. Proc Am Thorac Soc. 2:50–60. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Aoshiba K, Koinuma M, Yokohori N and Nagai
A: Immunohistochemical evaluation of oxidative stress in murine
lungs after cigarette smoke exposure. Inhal Toxicol. 15:1029–1038.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kobayashi H, Ouchi N, Kihara S, Walsh K,
Kumada M, Abe Y, Funahashi T and Matsuzawa Y: Selective suppression
of endothelial cell apoptosis by the high molecular weight form of
adiponectin. Circ Res. 94:e27–e31. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pang TT and Narendran P: The distribution
of adiponectin receptors on human peripheral blood mononuclear
cells. Ann N Y Acad Sci. 1150:143–145. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Akifusa S, Kamio N, Shimazaki Y, Yamaguchi
N and Yamashita Y: Regulation of globular adiponectin-induced
apoptosis by reactive oxygen/nitrogen species in RAW264
macrophages. Free Radic Biol Med. 45:1326–1339. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hattori Y, Suzuki M, Hattori S and Kasai
K: Globular adiponectin upregulates nitric oxide production in
vascular endothelial cells. Diabetologia. 46:1543–1549. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao HY, Zhao M, Yi TN and Zhang J:
Globular adiponectin protects human umbilical vein endothelial
cells against apoptosis through adiponectin receptor 1/adenosine
monophosphate-activated protein kinase pathway. Chin Med J (Engl).
124:2540–2547. 2011.PubMed/NCBI
|
